elon musk tirzepatide Musk's Weight Loss Transformation: How Mounjaro is Helping the Billionaire Shed Pounds Meet Grok, the first technology

There is also a more subtle risk worth knowing: the Pasqua 2025 trial reported two cases of euglycemic ketosis without acidosis in semaglutide-treated participants

People taking Wegovy average about 15% of body weight lost

When Symptoms Arise: If you notice any symptoms of potassium imbalance, such as muscle weakness, cramps, fatigue, or an irregular heartbeat, its important to contact your healthcare provider

FDA-approved as Mounjaro for type 2 diabetes and Zepbound for chronic weight management, tirzepatide targets both GIP and GLP-1 receptors to improve glucose regulation, reduce appetite, and promote weight loss

Tirzepatide, on the other hand, takes a dual-action approach by targeting both GLP-1 and GIP receptors